Home > Boards > Free Zone > All Fundamentals > $Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

thank you, CYDY

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mick Member Profile
Member Level 
Followed By 2,607
Posts 854,093
Boards Moderated 195
Alias Born 09/04/00
160x600 placeholder
mick Member Level  Wednesday, 09/11/19 07:28:45 PM
Re: trding post# 207028
Post # of 207530 
thank you, CYDY
RE;

Shareholders meeting tomorrow. CEO said they are going to discuss details of signed non-binding agreement apparently for significant milestone payments with some BP. Tomorrow could be very interesting.


Date: Thursday, September 12, 2019
Time: 9:30 a.m. PT / 12:30 p.m. ET
Dial In: For audio: 877-407-2986 or 201-378-4916
The live audio webcast may also be accessed via CytoDyn’s corporate website at

HTTP://www.cytodyn.com

under the Investors section/IR Calendar and will be archived for two weeks.

Web participants are encouraged to go to the website 15 minutes
prior to the start of the meeting to register,

download and install any necessary software.

The webcast can also be accessed via the following link:

https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/32197/indexl.html

=========================================================
CytoDyn Inc. (OTC: CYDY) Nader Pourhassan, Ph.D, CEO.

CEO Dr. Nader Pourhassan updates investors on the latest developments for CytoDyn’s lead drug candidate, Leronlimab (PRO 140) for use as a Combination Therapy to treat HIV, and expecting FDA approval in early 2020.
Dr. Pourhassan also shares what’s ahead for the company’s pipeline for cancer indications


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist